INTRODUCTION
============

Autism spectrum disorder (ASD) is a neurodevelopmental disorder involving deficits in social interaction along with restricted interests and repetitive and stereotypic patterns of behavior. The estimated prevalence of ASD based on the 2014 National Health Interview Survey was 2.24% with a more than three-fold increase since 2000. The male to female ratio is shown to be 4:1.[@b1-cpn-16-415] The widely reported increase of ASD cases has stimulated research in etiology through the recent decades.

It is currently accepted that ASD has substantial heritability. Specifically, twin studies have shown a concordance of 70.0% to 90.0% among monozygotic twins,[@b2-cpn-16-415] with much lower rates among dizygotic twins.[@b3-cpn-16-415],[@b4-cpn-16-415] The risk for a newborn child is increased more than ten times when a previous sibling has an ASD.[@b5-cpn-16-415] Genome-wide linkage and association studies have been done to search for susceptibility genes for ASD and several candidate genes have been showed to be involved in ASD.[@b6-cpn-16-415]--[@b11-cpn-16-415]

Although many genetic mechanisms have been elaborated in the pathogenesis of ASD, the complete picture of ASD pathogenesis at biochemical and genetic levels remains to be identified. Supporting this view, the known genetic variations account for only 10.0% to 20.0% of patients with ASD.[@b6-cpn-16-415],[@b12-cpn-16-415],[@b13-cpn-16-415] Therefore, rather than a single causative factor, the combination and interplay of heritability and environmental risk factors may be important in etiology of ASD.[@b13-cpn-16-415]

Among those factors, vitamin D and oxytocin may be important.[@b14-cpn-16-415]--[@b16-cpn-16-415] Vitamin D is important for neuronal embriyogenesis and development, immune neuromodulation, anti-oxidation, anti-apoptosis, neuronal differentiation and genetic regulation.[@b14-cpn-16-415] Some studies suggest that children with ASD may be deficient in vitamin D and that incidence of ASD may increase in offspring of mothers with vitamin D deficiency in pregnancy.[@b15-cpn-16-415] The observations that vitamin D, in its active form, contributes to regulation and expression of approximately 900 genes, most of which play role in brain development as well as its interactions with serotonergic metabolism and oxytocinmay support this view.[@b15-cpn-16-415],[@b17-cpn-16-415],[@b18-cpn-16-415] Contrarily, vitamin D metabolism may also be affected in other pediatric neurodevelopmental and neuropsychiatric disorders and its abnormalities may not be specific to ASD.[@b19-cpn-16-415]--[@b21-cpn-16-415] Also, rather than absolute vitamin D levels, receptor polymorphisms may be more important in neuropsychiatric functioning.[@b21-cpn-16-415]

Oxytocine (OXT) is a neuropeptide related with social behavior, affiliation/attachment, social memory, reward and reactivity to social stress in mammals.[@b22-cpn-16-415]--[@b26-cpn-16-415] Recent studies suggest that OXT may also be important for social cognition both in healthy humans as well as those with ASD and that exogenous applications of OXT may affect social behaviors albeit temporarily.[@b16-cpn-16-415],[@b25-cpn-16-415]--[@b31-cpn-16-415]

Genes for OXT and its receptor also contain vitamin D responsive elements (VDREs) changing their function (i.e., both production and response).[@b17-cpn-16-415],[@b18-cpn-16-415],[@b32-cpn-16-415],[@b33-cpn-16-415] VDREs colocalize with OXT in hypothalamic neurons, both interact with serotonergic metabolism and genetic variations in both have been associated with ASD; suggesting a role in etiology.[@b17-cpn-16-415],[@b18-cpn-16-415],[@b32-cpn-16-415]--[@b40-cpn-16-415] On the other hand; OXT levels as well as receptor polymorphisms may display their effects independent of the ASD diagnosis[@b41-cpn-16-415],[@b42-cpn-16-415] and changes in *VDR* were also reported for patients with ADHD.[@b43-cpn-16-415]

Converging lines of evidence suggest that vitamin D, *VDR*, OXT and its receptors may play roles in social behaviors.[@b15-cpn-16-415]--[@b18-cpn-16-415],[@b22-cpn-16-415]--[@b43-cpn-16-415] As far as we are aware, no study up to now attempted to evaluate polymorphisms in both *VDR* and *OXTR* in ASD. Therefore, we aimed to evaluate the contribution of *VDR* and *OXTR* gene polymorphisms in the development of autism spectrum disorder in a Turkish sample.

METHODS
=======

Study Center, Time Frame and Ethics
-----------------------------------

This study was conducted between January 2015 and January 2017 in the Child and Adolescent Psychiatry outpatient departments of Baskent University Faculty of Medicine and Mersin University Faculty of Medicine. Age- and gender-matched healthy controls were enrolled among elementary school students from two schools located in the epidemiological catchment areas of both departments. The study protocol has been approved by local ethics committee of the study center with a protocol number of MEU 2014/209. Parental informed assent and verbal assent of the children (if applicable) were procured prior to study entry. All of the study procedures were in accordance with the Declaration of Helsinki and local laws and regulations.

Inclusion and Exclusion Criteria
--------------------------------

Three to 18 year-old, patients with non-regressive, simplex-ASD (i.e., only index case among offspring),[@b44-cpn-16-415] according to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria,[@b45-cpn-16-415] with a score of \>29.5 (i.e., above cut-off for ASD) in the Turkish version of the Childhood Autism Rating Scale,[@b46-cpn-16-415] without known genetic syndromes (i.e., Down's syndrome, fragile X syndrome, Rett syndrome) or comorbid intellectual disability (as evaluated with developmental tests or Turkish version of the Wechsler Intelligence Scale for Children, revised edition along with clinical interviews) were included. The patients included those with autistic disorder, Asperger's disorder and pervasive developmental disorder-not otherwise specified (PDD-NOS) according to DSM fourth edition, text revision (DSM-IV-TR) criteria. The patients should also be free of of comorbid chronic medical and neurological disorders. Healthy controls should be free of life-time psychopathology as evaluated via Turkish version of the Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present/Lifetime Version (K-SADS-PL).[@b47-cpn-16-415] Parental informed consent and verbal assent of children (if applicable) were necessary for inclusion.

Power Analysis
--------------

Under a multiplicative model with significance level of 0.05 (not corrected for multiple comparisons), a disease prevelance of 1.0%, genotype relative risk of 1.2, disease allele frequency of 20.0% and at 1:1 case-to-control ratio we would need 2,000 cases for 70.0% power.[@b48-cpn-16-415]--[@b50-cpn-16-415] Within the time-frame and considering our load of patients with ASD we settled for 100 cases with ASD and 100 controls (i.e., 41.0% power). In the end we could enroll 85 patients with ASD and 52 controls leading to a power of approximately 30.0%.

Laboratory Analysis
-------------------

In both groups, DNA was extracted from peripheral blood transferred to ethilen dianmin acetic acid tubes. Genomic DNA was extracted from peripheral blood by using GF-1 blood DNA extraction kit (Vivantis Technologies^TM^, Oceanside, CA, USA) according to the manufacturer's instructions. *VDR* rs731236 (Taq1), rs2228570 (Fok1), rs1544410 (Bsm1) rs7975232 (Apa1) polymorphisms and *OXTR* rs1042778 and rs2268493 polymorphisms genotyping was performed with the TaqMan^®^ SNP Genotyping Assay (Applied Biosystems, Foster City, CA, USA). The polymerase chain reaction (PCR) reactions were carried out in a total volume of 25 μL containing TaqMan^®^ Genotyping Master Mix, TaqMan^®^ Genotyping AssayMix, DNase-free water and genomic DNA. The PCR conditions were 10 minutes at 95°C, followed by 40 cycles at 95°C for 15 seconds and 60°C for 1 minutes. The 96-well ABI 7500 Fast Real-Time PCR system was applied (Applied Biosystems).

Statistical Analysis
--------------------

In statistical analysis, SPSS ver. 11.5 (SPSS Inc., Chicago, IL, USA.) and MedCalc Statistical software version 10.4 (MedCacl Software bvba, Ostend, Belgium) programs were used. For comparisons between groups, chi square test, *t* test for independent samples and Mann-Whitney *U* tests were used and results were evaluated with 95.0% confidence intervals and *p*\<0.05 was considered statistically significant. All comparisons were two-tailed. Bonferroni adjustment was undertaken for multiple comparisons. Whether population distribution was balanced in ASD and control groups was analyzed with Hardy-Weinberg test.

RESULTS
=======

Within the specified time-frame 85 patients with a mean age of 7.38±4.01 years (84.7% male) and 52 healthy controls with a mean age of 7.46±3.87 years (75.0% male) could be enrolled. The groups were similar in terms of mean age and gender ratios (*p*=0.903 and 0.160; respectively) ([Table 1](#t1-cpn-16-415){ref-type="table"}).

Control subjects were significantly more likely to be first born and had more siblings. Their mothers were also significantly older than those of children with ASD.

Genotyping results of patients and healthy controls included in the study are summarized in [Table 2](#t2-cpn-16-415){ref-type="table"}.

VDR-Taq I displayed Hardy-Weinberg equilibrium only in patients with ASD (*p*=0.30) but did not display it in controls (*p*=0.03). All other SNPs of *VDR* were in equilibrium for both controls and patients with ASD. For *OXTR* SNPs only rs2268493 was not in equilibrium and only for controls (*p*=0.02). All other SNPs were in equilibrium.

No significant differences could be found between groups in terms of genotypes and allelles.

DISCUSSION
==========

This multi-center, cross-sectional, case-control study on polymorphisms of *VDR* and *OXTR* in age- and gender-matched patients with ASDs and healthy controls could not find a significant difference between groups.

ASD is a heterogeneous disorder that is characterized by impaired social communications/interactions, and restricted, repetitive behaviors. Latest prevalence figures cited were as high as 1 in 88 which denotes an increase of 600.0% from 1970s. The cause of this increase is still not entirely known, although earlier recognition and detection of milder cases on the spectrum were frequently listed as major contributors.[@b51-cpn-16-415],[@b52-cpn-16-415]

The increase in ASD prevalence has stimulated research on its genetic basis. Changes in at least 440 genes were reported in etiology. Of these, 7.0% to 20.0% include changes in number of copies, 5.0% to 7.0% involve polymorphisms in a single gene, and 5.0 % are single gene mutations associated with metabolic diseases.[@b6-cpn-16-415],[@b53-cpn-16-415]

Changes in levels of vitamin D as well as genetic variations in its metabolism as well as interaction with oxytocin were posited to play a role in ASD etiology.[@b14-cpn-16-415],[@b15-cpn-16-415] Vitamin D, in its active form plays role in brain development and functioning[@b17-cpn-16-415],[@b18-cpn-16-415] and interacts with serotonin and oxytocin,[@b15-cpn-16-415],[@b21-cpn-16-415],[@b33-cpn-16-415],[@b39-cpn-16-415] supporting a potential role in ASD. Previous reviews suggested that genetic variations affecting vitamin D levels and functioning could play a role in ASD.[@b54-cpn-16-415] Schmidt *et al*.[@b40-cpn-16-415] reported that *VDR* polymorphisms especially. TaqI and BsmI could be associated with ASD risk.[@b40-cpn-16-415] In another, recent study from Turkey, FokI, TaqI, and BsmI genotypes for *VDR* differed significantly between children with ASD and healthy controls.[@b39-cpn-16-415] An earlier study however, failed to find an association.[@b43-cpn-16-415] In our study we also could not find an association between SNP at *VDR* (TaqI, FokI, BsmI, and ApaI) and a diagnosis of ASD. This negative result may be due to low power of our study. Indeed, a *post-hoc* power analysis revealed that we could only achieve 30.0% power to refute the null hypothesis. Alternatively, our sampling method for simplex, non-regressive ASD cases may be inadequate (i.e., dependence on personal reports and pediatric consultations, lack of genetic testing for specific syndromes). Also, there may be false negatives among our sample due to "stoppage phenomenon".[@b7-cpn-16-415],[@b44-cpn-16-415] The patients as a whole varied in severity and included those who would be diagnosed with either autistic disorder, Asperger syndrome or PDD-NOS as per DSM-IV-TR criteria. This heterogeneity may have also affected our results. *VDR* TaqI and *OXTR* rs2268493 polymorphisms were also not in equilibrium among controls and this may have affected the results.

Variations in OXT function are also suggested among etiologies for ASDs.[@b16-cpn-16-415],[@b23-cpn-16-415],[@b29-cpn-16-415]--[@b31-cpn-16-415] SNPs in *OXTR* are known to affect social functions[@b37-cpn-16-415],[@b41-cpn-16-415] even without a formal diagnosis of ASD. Vitamin D also interacts with oxytocin in neural functioning.[@b17-cpn-16-415],[@b18-cpn-16-415] SNP rs1042778 at *OXTR* may increase social impairment in ASD[@b36-cpn-16-415],[@b37-cpn-16-415] while rs2268493 may affect speech and repetitive movements in addition to social skills in ASD.[@b37-cpn-16-415],[@b38-cpn-16-415] As for discrete diagnostic entities, rs2268493 was found to be associated with Asperger syndrome[@b55-cpn-16-415] while rs2268493 and rs1042778 were found to be associated with ASD.[@b37-cpn-16-415],[@b38-cpn-16-415],[@b56-cpn-16-415] However, a study from Japan failed to replicate the association of those polymorphisms with ASD.[@b57-cpn-16-415] We also failed to replicate this association. This may be due to heterogeneous and limited samples as well as low power. Our results should be confirmed with further studies on larger samples.

Finally, controls in our sample had more siblings and were more likely to be first born offspring of their mothers while patients with ASD had significantly younger mothers. While the first finding may be related to the "stoppage phenomenon" and the stresses of caring for a child with ASD, the second observation needs explanation.[@b44-cpn-16-415] We tried to sample simplex families which may select especially for copy number variations (CNVs) in etiology.[@b2-cpn-16-415]--[@b7-cpn-16-415],[@b44-cpn-16-415] While increasing parental age is known to be related with changes in germ cells and *de novo* CNVs, recent findings suggest that early parenthood may also be related with changes in germ cell lines.[@b58-cpn-16-415],[@b59-cpn-16-415] Our findings may reflect those observations although lack of genetic testing of parents in our sample precludes more definite hypotheses. The effects of early-parenthood on risk for ASD in offspring should be evaluated with further studies.

This multi-center, case-control study of SNPs in *OXTR* and *VDR* in ASD failed to find a significant association. The results may be affected by limited sample size and power and inadequate sampling of simplex cases. Further studies on larger ASD samples, preferably from differing geographical regions of Turkey are needed for confirmation of our results.
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###### 

Sociodemographic variables of children with autism spectrum disorder (ASD) and healthy controls

  Variable             ASD (n=85)   Healthy controls (n=52)   *p* value
  -------------------- ------------ ------------------------- --------------------------------------------------
  Age (yr)             7.38±4.01    7.46±3.87                 0.903
  Sex                                                         
   Male                72 (84.7)    39 (75.0)                 0.160
   Female              13 (15.3)    13 (25.0)                 
  Mother's age (yr)    34.98±6.51   38.94±6.35                0.001[\*](#tfn2-cpn-16-415){ref-type="table-fn"}
  Father's age (yr)    38.37±9.38   37.41±14.14               0.634
  Number of siblings   2 (1--2)     2 (1--3)                  0.007[\*](#tfn2-cpn-16-415){ref-type="table-fn"}
  Order of birth       2 (2--3)     1 (1--2)                  0.002[\*](#tfn2-cpn-16-415){ref-type="table-fn"}

Values are presented as mean±standard deviation, number (%), or median (range).

Mann-Whitney *U* or *t* tests.

###### 

Genotype and allele frequencies of children with autism spectrum disorder (ASD) and healthy controls for vitamin D and oxytocine receptors

  Gene     SNP                Genotype frequency   *p*[\*](#tfn4-cpn-16-415){ref-type="table-fn"}   Allele frequency   *p*[\*](#tfn4-cpn-16-415){ref-type="table-fn"}                                                                                     
  -------- ------------------ -------------------- ------------------------------------------------ ------------------ ------------------------------------------------ ----------- ----------- ------- ----------- ----------- ------------ ------------ -------
  *VDR*    rs731236 (Taq1)    21 (40.4)            28 (53.8)                                        3 (5.8)            37 (43.5)                                        35 (41.2)   13 (15.3)   0.157   70 (67.3)   34 (32.7)   109 (64.1)   61 (35.9)    0.590
  *VDR*    rs2228570 (Fok1)   4 (7.7)              20 (38.5)                                        28 (53.8)          5 (5.9)                                          31 (36.5)   49 (57.6)   0.870   28 (26.9)   76 (73.1)   41 (24.1)    129 (75.9)   0.604
  *VDR*    rs1544410 (Bsm1)   6 (11.5)             26 (50.0)                                        20 (38.5)          11 (12.9)                                        40 (47.1)   34 (40.0)   0.938   38 (36.5)   66 (63.5)   62 (36.5)    108 (63.6)   0.991
  *VDR*    rs7975232 (Apa1)   0 (0.0)              35 (67.3)                                        17 (32.7)          2 (2.4)                                          56 (65.9)   27 (31.8)   0.537   35 (33.7)   69 (66.3)   60 (35.3)    110 (64.7)   0.782
  *OXTR*   rs1042778          19 (36.5)            28 (53.8)                                        5 (9.6)            30 (35.3)                                        40 (47.1)   15 (17.6)   0.419   66 (63.5)   38 (36.5)   100 (58.8)   100 (58.8)   0.446
  *OXTR*   rs2268493          0 (0.0)              20 (38.5)                                        32 (61.5)          6 (7.1)                                          28 (32.9)   51 (60.0)   0.138   20 (19.2)   84 (80.8)   40 (23.5)    130 (76.5)   0.404

Values are presented as number (%).

Hardy-Weinberg test.
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